Vast Therapeutics
Vast Therapeutics, with a valuation of $49.85 million, is raising funds on StartEngine. It is a life sciences company focused on improving the lives of the patients with chronic respiratory diseases. Vast Therapeutics has recently received the FDA clearance for Phase 1 clinical trials for its lead product candidate, ALX1, which aims to address inflammation and infection with a dual-action approach. The company is led by an experienced team and is well positioned to address significant unmet medical needs. Nate Stasko founded Vast Therapeutics in April 2017. The current crowdfunding campaign has a minimum target of $123,999.20 and a maximum target of $1.24 million. The campaign proceeds will be used for research and development, company employment, and working capital.
Investment Overview
Raised: $194,540
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 11/20/2024
- Close Date
- 02/17/2025
$123,999
$1,235,000
$468
Equity - Preferred
RegCF
$1.04
$49,849,620
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Morrisville, North Carolina
- Company Website
-
Visit Website
Team
- Employees
- 8
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/17/2025 | StartEngine | $49,849,620 | $194,540 | Equity - Preferred | Active | RegCF |